Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia

Pediatrics

Volumn 101, Issue 5, 1998, Pages 870-874

  Banks, Beverly A ^a   Ischiropoulos, Harry ^a,c   McClelland, Molly ^a   Ballard, Philip L ^a   Ballard, Roberta A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c AMERICAN HEART ASSOCIATION   (United States)

Author keywords

Bronchopulmonary dysplasia; Nitrotyrosine; Oxidant stress; Peroxynitrite; Premature infant

Indexed keywords

3 NITROTYROSINE; BIOCHEMICAL MARKER; CORTICOSTEROID; PROTIRELIN; SURFACTANT;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPEROXIA; INFANT; LUNG DYSPLASIA; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; OXIDATIVE STRESS; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL;

EID: 0031924821     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.5.870     Document Type: Article

References (29)

1. Sobel DB, Carroll A. Post surfactant slump: early prediction of neonatal chronic lung disease? J Perinatol. 1994;14:268-274
2. Koops BL, Abman SH, Accurso FJ. Outpatient management and follow-up of BPD. Clin Perinatol. 1984;11:101-122
3. Zimmerman JJ, Farrell PM. Advances and issues in bronchopulmonary dysplasia. Curr Probl Pediatr. 1994;24:159-170
4. Freeman B. Free radical chemistry of nitric oxide: looking at the dark side. Chest. 1994;105:79S-84S
5. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite mediated tyrosine nitration catalyzed by Superoxide dismutase. Arch Biochem Biophys. 1992;298:431-437
6. Ischiropoulos H, Al-Mehdi A, Fisher AB. Reactive species in rat lung ischemia: contribution of peroxynitrite. Am J Physiol. 1995;269: L158-L164
7. Ischiropoulos H, Beers MF, Ohnishi ST. Nitric oxide production and perivascular tyrosine nitration in brain following carbon monoxide poisoning in the rat. J Clin Invest. 1996;97:2260-2267
8. Kooy NW, Royall JA, Ye Y-Z, et al. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med. 1995;151:1250-1254
9. Haddad IY, Pataki G, Hu P, et al. Quantitation of 3-nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest. 1994;94:2407-2413
10. Banks BA, Seri I, Ischiropoulos H, Bridges N, Rychik J, Ballard RA. Inhaled nitric oxide (INO) in infants with severe ventilator dependent bronchopulmonary dysplasia (BPD). Pediatr Res. 1997;41:246A. Abstract
11. Banks BA, Seri I, McClelland MM, Ballard RA, Ischiropoulos H. Plasma nitrotyrosine (PNT) in full term infants treated with inhaled nitric oxide (INO) for persistent pulmonary hypertension of the newborn (PPHN). Pediatr Res. 1997;41:138A. Abstract
12. Ballard RA, Ballard PL, Cnann A, et al. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. N Engl J Med. 1998;338:493-498
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254
14. Gow A, Duran A, Thom SR, et al. Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration. Arch Biochem Biophys. 1996;333:42-48
15. Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage derived nitric oxide. Arch Biochem Biophys. 1992;298: 446-451
16. Huie RE, Padjama S. The reaction of nitric oxide with Superoxide. Free Radic Res Commun. 1993;18:195-199
17. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of Superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:481-487
18. King PA, Jamison E, Strahs D, et al. Footprinting proteins on DNA with peroxynitrous acid. Nucleic Acid Res. 1993;21:2473-2478
19. Haddad IY, Ischiropoulos H, Holm BA, et al. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol. 1993;265: L555-L564
20. Miles PR, Bowman L, Huffman L. Nitric oxide alters metabolism in isolated alveolar type II cells. Am J Physiol. 1996;271:L23-L30
21. Bauer M, Beckman JS, Bridges R, et al. Peroxynitrite inhibits sodium transport in rat colonic membrane vesicles. Biochem Biophys Acta. 1992; 1104:87-94
22. Gladstone IM Jr, Levine RL. Oxidation of proteins in neonatal lungs. Pediatrics. 1994;93:764-768
23. Versila E, Pesonen E, Anderson S. Early protein oxidation with neonatal lung is related to development of chronic lung disease. Acta Paediatr. 1995;84:1296-1299
24. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA. 1990;87: 10043-100047
25. Szabo C, Salzman AL, Ischiropoulos H. Peroxynitrite mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett. 1995; 372:229-232
26. Haddad IY, Zhu S, Ischiropoulos H, et al. Nitration of surfactant protein (SP-A) results in decreased ability to aggregate lipids. Am J Physiol. 1996;270:L2281-L2288
27. Kaur H, Halliwell B. Evidence of nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 1994;350:9-12
28. Fukuyama N, Takebayashi Y, Hida M, Ishida H, Ichimori K, Nakazawa H. Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock. Free Radic Biol Med. 1997;22:771-774
29. Myatt L, Rosenfield RB, Eis AL, Brockman DE, Greer I, Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension. 1996;28:488-493